94 related articles for article (PubMed ID: 16777098)
1. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
[TBL] [Abstract][Full Text] [Related]
2. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
Day JR; Van Damme N; Guatelli JC
Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
[TBL] [Abstract][Full Text] [Related]
3. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
Li Y; Luo L; Thomas DY; Kang CY
Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
[TBL] [Abstract][Full Text] [Related]
4. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
5. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
6. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
[TBL] [Abstract][Full Text] [Related]
8. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.
Iwatani Y; Kawano K; Ueno T; Tanaka M; Ishimoto A; Ito M; Sakai H
Virology; 2001 Jul; 286(1):45-53. PubMed ID: 11448157
[TBL] [Abstract][Full Text] [Related]
9. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
Martin G; Beauséjour Y; Thibodeau J; Tremblay MJ
Virology; 2005 May; 335(2):286-90. PubMed ID: 15840527
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of erythropoietin's signal peptide for HIV(MN)-1 gp 120 expression.
Herrera AM; Musacchio A; Fernández JR; Duarte CA
Biochem Biophys Res Commun; 2000 Jul; 273(2):557-9. PubMed ID: 10873644
[TBL] [Abstract][Full Text] [Related]
11. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
12. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
13. Effect of promoters and signal sequences on the production of secreted HIV-1 gp120 protein in the baculovirus system.
Golden A; Austen DA; van Schravendijk MR; Sullivan BJ; Kawasaki ES; Osburne MS
Protein Expr Purif; 1998 Oct; 14(1):8-12. PubMed ID: 9758745
[TBL] [Abstract][Full Text] [Related]
14. The transmembrane protein of HIV-1 primary isolates modulates cell surface expression of their envelope glycoproteins.
Lebigot S; Roingeard P; Thibault G; Lemiale F; Verrier B; Barin F; Brand D
Virology; 2001 Nov; 290(1):136-42. PubMed ID: 11882998
[TBL] [Abstract][Full Text] [Related]
15. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.
Lindemann D; Pietschmann T; Picard-Maureau M; Berg A; Heinkelein M; Thurow J; Knaus P; Zentgraf H; Rethwilm A
J Virol; 2001 Jul; 75(13):5762-71. PubMed ID: 11390578
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain.
Wilk T; Pfeiffer T; Bukovsky A; Moldenhauer G; Bosch V
Virology; 1996 Apr; 218(1):269-74. PubMed ID: 8615034
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions.
Devitt G; Emerson V; Holtkotte D; Pfeiffer T; Pisch T; Bosch V
Virology; 2007 May; 361(2):465-71. PubMed ID: 17208268
[TBL] [Abstract][Full Text] [Related]
18. Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
Beauséjour Y; Tremblay MJ
Virology; 2004 Jun; 324(1):165-72. PubMed ID: 15183063
[TBL] [Abstract][Full Text] [Related]
19. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
20. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
Roda Rani KP; Pelluru D; Kondapi AK
Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]